1. Biology

Newborn daughters get a fresh start through PI(3,5)P 2 -mediated vacuolar acidification

Written by Posted on Less than 0 min read

Huda et al. (https://doi.org/10.1083/jcb.202406170) reveal a transient, cell cycle–dependent increase in PI(3,5)P2 levels at the lysosome-like vacuole of yeast daughter cells. The resulting lipid asymmetry alters vacuolar pH in both daughter and mother cells and will impact multiple downstream functions.

Member since

More from Admin

Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

New sunflower household tree reveals a number of origins of flower symmetry

The sunflower household tree revealed that flower symmetry developed a number of instances independently, a course of referred to as convergent evolution, among the many members of this massive plant household, in keeping with a brand new evaluation. The analysis group, led by a Penn State biologist, resolved extra of the finer branches of the […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Evolution of taste: Early sharks were able to perceive bitter substances

A research team from the University of Cologne, in collaboration with colleagues from the Leibniz Institute for Food Systems Biology in Freising, has discovered a receptor for bitter taste in twelve different cartilaginous fish (sharks and rays). The receptor belongs to the so-called taste receptors type 2 (T2R), which also make humans perceive bitter and […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

The reasons flowers wilt could explain how plants spend (and save) their energy

A study in the journal Plant Biology by researchers from Macquarie University and international collaborators has shown for the first time, that plants reuse resources from wilting flowers to support future reproduction. Lead author Honorary Professor Graham Pyke from Macquarie University says the findings help explain a common but poorly understood plant process. “Our research […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Could a dietary fiber supplement offer long-awaited treatment for food allergy sufferers?

A study from the University of Michigan has identified a potential new treatment for food allergies in inulin, a naturally occurring plant fiber commonly used as a supplement, a prebiotic in soda, a replacement for sweeteners and for other products and purposes. In what appears to be a major advancement that offers the promise of […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

How domestic rabbits become feral in the wild

Researchers at the Texas A&M School of Veterinary Medicine and Biomedical Sciences (VMBS) have uncovered how natural selection “rewilds” domestic rabbits. The study, published in Nature Ecology and Evolution, helps answer the question of how normally tame rabbits — which have many natural predators — can become a force of ecological destruction when purposefully or […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Early Homo sapiens facilitated the establishment of the Bonelli’s eagle in the Mediterranean 50,000 years ago

A team of Spanish and Portuguese scientists led by the UGR have unravelled the ancestral history of one of the most iconic birds of prey in the current Iberian fauna: the Bonelli’s eagle (Aquila fasciata). The study, published in the scientific journal People and Nature, combines evidence from several disciplines, including palaeontology, genetics and ecology, […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

How to slow the spread of deadly ‘superbugs’

Harnessing new advances in genomic surveillance technology could help detect the rise of deadly ‘superbugs’ and slow their evolution and spread, improving global health outcomes, a new Australian study suggests. Antimicrobial resistance occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to the medicines and chemicals we use to kill […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Close encounters between distant DNA regions cause bursts of gene activity

Researchers at Kyushu University have revealed how spatial distance between specific regions of DNA is linked to bursts of gene activity. Using advanced cell imaging techniques and computer modeling, the researchers showed that the folding and movement of DNA, as well as the accumulation of certain proteins, changes depending on whether a gene is active […]
Written by
  1. Clinical

Final Results from a Phase 2 Study of TPN-101 for the Treatment of C9orf72-Related Amyotrophic Lateral Sclerosis and/or Frontotemporal Dementia

SAN DIEGO, July 24, 2024. Transposon Therapeutics, a biotechnology company developing a platform of novel, orally administered therapies for the treatment of neurodegenerative and aging-related diseases, including Alzheimer’s disease, today announced final results from its Phase 2 study of TPN-101 in patients with amyotrophic lateral sclerosis (ALS) and/or frontotemporal dementia (FTD) related to hexanucleotide repeat […]
Written by
  1. Clinical

Understanding the Role of Clinical Studies in Drug Development

Understanding the Role of Clinical Studies in Drug Development Clinical studies, also known as clinical trials, play a crucial role in the development of new drugs and medical interventions. They are an essential step in determining the safety and efficacy of a potential treatment before it can be approved and made available to the general […]
Written by
  1. Clinical

Sage Therapeutics and Biogen Announce Topline Results from Phase 2 KINETIC 2 Study of SAGE-324 (BIIB124) for the Treatment of Essential Tremor

CAMBRIDGE Mass. – July 24, 2024 – Sage Therapeutics, Inc. (NASDAQ: Sage) and Biogen Inc. (NASDAQ: BIIB) announced topline results from the Phase 2 KINETIC 2 dose-range study of the oral investigational drug SAGE-324 (BIIB124) as a potential treatment in essential tremor (ET). The KINETIC 2 Study did not demonstrate a statistically significant dose-response relationship […]
Written by
  1. Clinical

First Patient Dosed in the MAD Part 2 Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity

CAMBRIDGE, Mass., June 26, 2024. NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced dosing of the first patient in the multiple ascending dose (MAD) Part 2 of its Phase 1 clinical trial of DA-1726, a novel, dual oxyntomodulin (OXM) analog agonist that functions as a glucagon-like peptide-1 receptor (GLP1R) […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Clinical

FDA Clears Application to Initiate Phase 1 Clinical Study of oral Immunotherapy for the Treatment of Rheumatoid Arthritis

ROCKVILLE, Md., Oct. 19, 2023. – Rise Therapeutics, a biotechnology company engaged in developing novel oral immunotherapeutics, today announced that the U.S. Food and Drug Administration (FDA) has accepted its investigational new drug (IND) application to proceed with a rheumatoid arthritis Phase 1 clinical trial for its program candidate, R-2487. This is Rise Therapeutics’ second […]
Written by
  1. Clinical

Tonix Prescription drugs Receives Uncommon Pediatric Illness Designation from the FDA for TNX-2900 for the Therapy of Prader-Willi Syndrome

CHATHAM, N.J., March 25, 2024 (GLOBE NEWSWIRE) — Tonix Prescription drugs Holding Corp. (Nasdaq: TNXP) (Tonix or the Firm), a biopharmaceutical firm with marketed merchandise and a pipeline of growth candidates, as we speak introduced the U.S. Meals and Drug Administration (FDA) has granted Uncommon Pediatric Illness Designation to TNX-2900* (intranasal potentiated oxytocin), a proprietary […]
Written by
  1. Biology

Building a COMPASS to navigate future pandemics

Viruses like SARS-CoV-2 don’t respect boundaries, moving between species and continents and leaving destruction as they go. Beating the next pathogen with pandemic potential means getting good at crossing borders ourselves — between fields of study, between research universities, and between scientists and the wider community. Viruses like SARS-CoV-2 don’t respect boundaries, moving between species […]
Written by
  1. Biology

Preserve or destroy: Orphan protein proteostasis and the heat shock response

Most eukaryotic genes encode polypeptides that are either obligate members of hetero-stoichiometric complexes or clients of organelle-targeting pathways. Proteins in these classes can be released from the ribosome as “orphans”—newly synthesized proteins not associated with their stoichiometric binding partner(s) and/or not targeted to their destination organelle. Here we integrate recent findings suggesting that although cells […]
Written by
  1. Biology

At-risk butterflies more likely to survive with human help

VANCOUVER, Wash. –  Some of the butterflies most in danger of fluttering out of existence fare better when their habitats are actively managed by humans, a recent study found. VANCOUVER, Wash. –  Some of the butterflies most in danger of fluttering out of existence fare better when their habitats are actively managed by humans, a […]
Written by
  1. Biology

Exploring the impact of attentional uniqueness and attentional allocation

According to the attention-based view, a firm’s actions and growth performance are directly influenced by its attentional allocation to specific issues. The consequences of organizational attention are reflected in the firm’s strategic decision-making and adaptability. However, existing literature is limited in its exploration of how a firm’s attentional uniqueness impacts its behavior and performance. Notably, […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

New Indication for Motpoly XR (Lacosamide Extended-Release) Capsules for Primary Generalized Tonic-Clonic Seizures (Adjunctive Treatment)

Generic name: lacosamideTreatment for: Seizures New Indication for Motpoly XR New Indication for Motpoly XR (Lacosamide Extended-Release) Capsules for Primary Generalized Tonic-Clonic Seizures (Adjunctive Treatment) SILVER SPRING, MD. June 7, 2024/FDA Approvals/ — Today, the U.S. Food and Drug Administration (FDA) granted Aucta Pharmaceuticals a prior approval supplemental new drug application for the use of […]
Written by
Next
No Comments
Leave a comment Cancel
Comments to: Newborn daughters get a fresh start through PI(3,5)P 2 -mediated vacuolar acidification

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.